EG22263A - Process for preparing hydroxamic acids - Google Patents

Process for preparing hydroxamic acids

Info

Publication number
EG22263A
EG22263A EG37399A EG37399A EG22263A EG 22263 A EG22263 A EG 22263A EG 37399 A EG37399 A EG 37399A EG 37399 A EG37399 A EG 37399A EG 22263 A EG22263 A EG 22263A
Authority
EG
Egypt
Prior art keywords
hydroxamic acids
preparing hydroxamic
preparing
acids
hydroxamic
Prior art date
Application number
EG37399A
Other languages
English (en)
Inventor
Joel M Hawking
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of EG22263A publication Critical patent/EG22263A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/14Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
EG37399A 1998-04-10 1999-04-08 Process for preparing hydroxamic acids EG22263A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
EG22263A true EG22263A (en) 2002-11-30

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
EG37399A EG22263A (en) 1998-04-10 1999-04-08 Process for preparing hydroxamic acids

Country Status (38)

Country Link
US (1) US6288246B1 (xx)
EP (1) EP0949244A3 (xx)
JP (1) JPH11343277A (xx)
KR (1) KR100329902B1 (xx)
CN (1) CN1232023A (xx)
AP (1) AP1203A (xx)
AR (1) AR018180A1 (xx)
AU (1) AU747629B2 (xx)
BG (1) BG64154B1 (xx)
BR (1) BR9901089A (xx)
CA (1) CA2268680A1 (xx)
CO (1) CO5070713A1 (xx)
DZ (1) DZ2757A1 (xx)
EA (1) EA002777B1 (xx)
EG (1) EG22263A (xx)
GT (1) GT199900046A (xx)
HR (1) HRP990105A2 (xx)
HU (1) HUP9901041A3 (xx)
ID (1) ID23337A (xx)
IL (1) IL129328A0 (xx)
IN (1) IN192342B (xx)
IS (1) IS5019A (xx)
MA (1) MA24831A1 (xx)
NO (1) NO991672L (xx)
NZ (1) NZ335104A (xx)
OA (1) OA11031A (xx)
PA (1) PA8469301A1 (xx)
PE (1) PE20000418A1 (xx)
PL (1) PL332450A1 (xx)
SG (1) SG125880A1 (xx)
SK (1) SK43699A3 (xx)
TN (1) TNSN99052A1 (xx)
TR (1) TR199900755A2 (xx)
TW (1) TW448147B (xx)
UA (1) UA57750C2 (xx)
UY (1) UY25460A1 (xx)
YU (1) YU18199A (xx)
ZA (1) ZA992631B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
RU2326862C2 (ru) * 2003-08-29 2008-06-20 Басф Акциенгезельшафт Способ получения о-замещенных гидроксиламиновых соединений
EP3082995A4 (en) 2013-12-18 2017-07-05 Brita LP Filter assembly for filter as you pour filtration
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Alk﹘5抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
TR199900387T2 (xx) 1996-08-23 1999-04-21 Pfizer Inc. Arils�lfonilamino hidroksamik asit t�revleri.
EA002594B1 (ru) 1997-02-03 2002-06-27 Пфайзер Продактс Инк. Производные арилсульфониламиногидроксамовой кислоты
ATE217863T1 (de) 1997-08-08 2002-06-15 Pfizer Prod Inc Arylsulfonylaminohydroxamsäurederivate
PT1003720E (pt) 1997-08-08 2004-07-30 Pfizer Prod Inc Derivados de acido ariloxiarilsulfonilamino hidroxamico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
PL332450A1 (en) 1999-10-11
NZ335104A (en) 2000-10-27
IL129328A0 (en) 2000-02-17
BG64154B1 (bg) 2004-02-27
IS5019A (is) 1999-10-11
BR9901089A (pt) 2000-05-30
KR19990083051A (ko) 1999-11-25
EA002777B1 (ru) 2002-08-29
TNSN99052A1 (fr) 2005-11-10
AP9901503A0 (en) 1999-06-30
EP0949244A3 (en) 2001-05-30
SK43699A3 (en) 2000-06-12
EA199900284A3 (ru) 2000-04-24
IN192342B (xx) 2004-04-10
PE20000418A1 (es) 2000-05-23
NO991672L (no) 1999-10-11
JPH11343277A (ja) 1999-12-14
KR100329902B1 (ko) 2002-03-22
YU18199A (sh) 2002-11-15
DZ2757A1 (fr) 2003-09-15
PA8469301A1 (es) 2000-09-29
CA2268680A1 (en) 1999-10-10
EA199900284A2 (ru) 1999-10-28
AR018180A1 (es) 2001-10-31
TW448147B (en) 2001-08-01
ZA992631B (en) 2000-10-09
UA57750C2 (uk) 2003-07-15
HUP9901041A3 (en) 2003-02-28
HRP990105A2 (en) 2000-02-29
CO5070713A1 (es) 2001-08-28
AU747629B2 (en) 2002-05-16
AU2369099A (en) 1999-10-21
AP1203A (en) 2003-09-05
GT199900046A (es) 2000-09-15
BG103319A (en) 2001-08-31
OA11031A (en) 2002-02-07
US6288246B1 (en) 2001-09-11
HUP9901041A2 (hu) 2000-03-28
MA24831A1 (fr) 1999-12-31
CN1232023A (zh) 1999-10-20
UY25460A1 (es) 1999-11-17
TR199900755A3 (tr) 1999-11-22
ID23337A (id) 2000-04-05
SG125880A1 (en) 2006-10-30
EP0949244A2 (en) 1999-10-13
NO991672D0 (no) 1999-04-09
TR199900755A2 (xx) 1999-11-22
HU9901041D0 (en) 1999-06-28

Similar Documents

Publication Publication Date Title
IL126264A0 (en) Process for preparing lactic acid
HUP9902419A3 (en) Process for preparing nitrobiphenylene
CZ20012118A3 (cs) Způsob výroby 3-alkanoylindolu a 3-alkylindolu
PL346582A1 (en) Process for preparing carboxylic acids
SG70092A1 (en) Process for preparing dialkylnaphthalene
IL134059A0 (en) Process for preparing aminoarylacetylenes
GB9929570D0 (en) Process for the preparation of para-oxadiazolylphenylboronic acids
EG22263A (en) Process for preparing hydroxamic acids
IL133121A0 (en) Process for making 2-alkyl-3-hydroxybenzoic acids
EG23935A (en) Process for preparing eprosartin
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP1089978A4 (en) METHOD FOR PRODUCING OXIMIDAZOLES
EG22139A (en) Process for preparing 4- substituted-1H-indole -3- glyoxamides
IL126184A (en) Process for preparing pentafluoropentanol
HUP0100253A3 (en) Process for preparing (r)-2-bromo-3-phenyl-propionic acid
GB2317178B (en) Process for preparing 1-chloromethylsilatrane
HUP0003069A3 (en) Process for preparing amides
IL133288A (en) Process for preparing 3-isochromanone
IL125646A (en) Process for preparing N-pyruvyl-L-proline
EP1119549A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES
GB9810502D0 (en) Process for preparing distrylbiphenyl compounds
MD810F1 (en) Process for modified ionites obtaining
HUP0104120A3 (en) A process for the preparation of alpha-arylalkanoic acids
GB9825422D0 (en) Process for preparing pollyketones
GB9800066D0 (en) Process for preparing dibenzocycycloheptene compounds